quinazolines has been researched along with Dengue in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calderón-Garcia, EJ; De Jesús-González, LA; Del Angel, RM; Hernández-Rivas, R; Pérez-Olais, JH; Ruiz-Jiménez, F | 1 |
| Chen, RY; Lee, YR; Lin, YS; Liu, HS; Wu, SY; Yeh, TM | 1 |
| Alvarez-Mon, M; Duran, A; Fuenmayor, E; Mosquera, J; Valero, N | 1 |
| Bekerman, E; Einav, S | 1 |
4 other study(ies) available for quinazolines and Dengue
| Article | Year |
|---|---|
The activity of Aurora kinase B is required for dengue virus release.
Topics: Antiviral Agents; Aurora Kinase B; Benzamides; Cell Line, Tumor; Cell Survival; Dengue; Dengue Virus; Gene Silencing; Humans; Quinazolines; Virus Release | 2019 |
Regulation of autophagy, glucose uptake, and glycolysis under dengue virus infection.
Topics: A549 Cells; Amiodarone; Animals; Animals, Newborn; Autophagy; Autophagy-Related Protein 5; Benzylamines; Biological Transport; Brain; Chlorocebus aethiops; Dengue; Dengue Virus; Gene Expression Regulation; Glucose; Glucose Transporter Type 1; Glycolysis; Hexokinase; Host-Pathogen Interactions; Humans; Mice; Mice, Inbred ICR; Microtubule-Associated Proteins; Phosphofructokinases; Quinazolines; Signal Transduction; Vero Cells; Virus Replication | 2020 |
Gefitinib and pyrrolidine dithiocarbamate decrease viral replication and cytokine production in dengue virus infected human monocyte cultures.
Topics: Adult; Animals; Antiviral Agents; Cell Line; Cells, Cultured; Culicidae; Cytokines; Dengue; Dengue Virus; ErbB Receptors; Gefitinib; Humans; Male; Monocytes; NF-kappa B; Nod2 Signaling Adaptor Protein; Protein Kinase Inhibitors; Pyrrolidines; Quinazolines; Thiocarbamates; Virus Replication | 2017 |
Infectious disease. Combating emerging viral threats.
Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses | 2015 |